Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Helius Medical Technologies In - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
HSDT
Nasdaq
3845
https://heliusmedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Helius Medical Technologies In
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 28th, 2024 8:05 pm
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
- Mar 15th, 2024 11:05 am
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
- Mar 12th, 2024 12:59 pm
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
- Mar 7th, 2024 12:00 pm
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
- Mar 4th, 2024 12:00 pm
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
- Feb 6th, 2024 12:00 pm
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
- Feb 5th, 2024 12:05 pm
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
- Jan 11th, 2024 12:00 pm
Wall Street Analysts Predict a 1249.93% Upside in Helius Medical Technologies, Inc. (HSDT): Here's What You Should Know
- Dec 7th, 2023 2:55 pm
Helius Medical Technologies to Present at NobleCon19 Annual Conference
- Nov 30th, 2023 12:47 pm
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript
- Nov 13th, 2023 4:07 pm
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 9:05 pm
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
- Nov 6th, 2023 12:05 pm
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024
- Nov 2nd, 2023 9:05 pm
3 Metaverse Stocks to Invest in for the Internet’s Next Evolution
- Oct 20th, 2023 6:34 pm
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices
- Oct 12th, 2023 11:05 am
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences
- Oct 2nd, 2023 11:05 am
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
- Sep 28th, 2023 11:00 am
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference
- Sep 21st, 2023 11:05 am
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
- Sep 20th, 2023 11:05 am
Scroll